Thymoma
📧 Sign up to get email alerts when something new happens for Thymoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-27Clinical Trial Update: Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma [Phase 3]
A Phase 3 trial evaluating adjuvant treatment for incomplete resection thymoma or thymic carcinoma has been withdrawn.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection [NA]
This clinical trial update reports ongoing recruitment for adjuvant radiotherapy after complete surgical resection in patients with Stage II…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy [Phase 2]
This update describes a Phase 2 pilot study assessing the safety and clinical activity of Avelumab in patients with thymoma or thymic carcin…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01) [NA]
A multicenter Phase III trial comparing conformal postoperative radiotherapy vs surveillance after complete resection of stage II/III thymom…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: 177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours [Phase 1]
Phase 1 trial update evaluating the combination of 177Lu-DOTA-TATE with Olaparib in somatostatin receptor-positive tumors has completed. The…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
NCI is recruiting for a tissue procurement and natural history study in patients with malignant mesothelioma, with thymoma listed among the …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma [Phase 2]
This report provides an update on a Phase 2 clinical trial of bintrafusp alfa (M7824) in patients with thymic epithelial tumors, thymoma, an…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: PT-112 in Subjects With Thymoma and Thymic Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating PT-112 in patients with thymoma and thymic carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection [NA]
Clinical trial update on adjuvant hypofractionation radiotherapy after complete resection of thymic epithelial tumors, with the trial curren…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: 6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is evaluating whether six cycles of neoadjuvant chemotherapy provide different outcomes than three cycles f…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: HEARTS Trial for Thoracic Cancers [Phase 2]
HEARTS is a Phase 2 clinical trial targeting thoracic cancers, including non-small cell lung cancer, esophageal cancer, esophagogastric canc…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma [NA]
An investigational MRI imaging study for thymoma is being evaluated in patients, including newly diagnosed and recurrent disease. The study …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis
A clinical trial from Shanghai General Hospital evaluates electrocautery resection with hyperthermic intrathoracic chemotherapy (HITHOC) for…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer [Phase 1]
A phase 1 trial evaluating pembrolizumab for unresectable thymoma or thymic carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors [Phase 2]
Phase II trial investigating sacituzumab govitecan in advanced thymic epithelial tumors is currently recruiting.
-
CLINICAL_TRIALS other · 2026-01-07Clinical Trial Update: Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma [Phase 2]
Phase 2 clinical trial evaluating chemotherapy plus cetuximab followed by surgical resection for locally advanced or recurrent thymoma or th…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Molecular Analysis of Thoracic Malignancies
This clinical trial update describes ongoing molecular analyses of thoracic malignancies, including thymic tumors and thoracic carcinomas, w…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: SP Thoracic IDE Study [NA]
Clinical trial update for Intuitive Surgical's SP Thoracic IDE Study. Results have been posted and the trial is active but not recruiting, w…
-
CLINICAL_TRIALS other · 2025-12-01Clinical Trial Update: Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma [Phase 2]
A Phase 2 clinical trial is evaluating tislelizumab in combination with anlotinib as second-line therapy for thymoma and thymic carcinoma, a…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET) [NA]
A clinical trial led by Institut Curie to characterize the immune infiltrate and molecular features of thymic epithelial tumors (thymomas an…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors [Phase 2]
A Phase 2 clinical study evaluating carbon ion radiotherapy combined with chemotherapy for thymic epithelial tumors (thymoma and thymic carc…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor [Phase 2]
A Phase 2 clinical trial evaluating postoperative proton radiotherapy for thymic epithelial tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma [Phase 2]
A Phase 2 clinical trial is evaluating neoadjuvant radiotherapy for locally advanced unresectable thymoma. The study is currently recruiting…
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: IL-8+ naïve T Cells as a Biomarker for Thymoma Identification
A completed clinical trial investigates IL-8+ naïve T cells as a biomarker for identifying thymoma.
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma [Phase 2]
Phase 2 clinical trial evaluating glucocorticoids in combination with concurrent chemoradiotherapy for unresectable thymoma, currently recru…